ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,795,000 | -75.9% | 276,170 | -87.3% | 0.01% | -75.9% |
| Q1 2019 | $52,993,000 | +28.6% | 2,173,616 | -24.8% | 0.05% | +14.9% |
| Q4 2018 | $41,210,000 | -13.0% | 2,891,911 | -7.2% | 0.05% | +2.2% |
| Q3 2018 | $47,377,000 | +8.1% | 3,116,886 | +19.4% | 0.05% | +4.5% |
| Q2 2018 | $43,808,000 | +69.0% | 2,610,740 | +64.4% | 0.04% | +69.2% |
| Q1 2018 | $25,922,000 | +1725.5% | 1,588,370 | +410.0% | 0.03% | +1200.0% |
| Q3 2015 | $1,420,000 | +56.2% | 311,468 | +147.1% | 0.00% | +100.0% |
| Q2 2015 | $909,000 | – | 126,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|